Search Details

Word: cancers (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...popular minimally invasive prostate cancer procedure increases a patient’s risk for erectile dysfunction and incontinence, Harvard researchers reported last week in the Journal of the American Medical Association...

Author: By Stephanie B. Garlock, CONTRIBUTING WRITER | Title: Surgical Outcomes Are Questioned | 10/23/2009 | See Source »

...only 20% of drugs on the market today are biologics, it is expected that, with 633 biotechnology medicines in development last year for more than 100 diseases, half the new drugs approved in 2015 will be. Biologics average more than 20 times the cost of traditional drugs: treating breast cancer with a year's worth of the biologic Herceptin can cost $48,000; Remicade, for rheumatoid arthritis, can cost $20,000 annually. For other, rarer diseases, the price of biologic treatments can be as high as $200,000 a year...

Author: /time Magazine | Title: How Drug-Industry Lobbyists Won on Health-Care | 10/22/2009 | See Source »

...July, one calling itself the National Health Council wrote letters to members of Congress "on behalf of 133 million Americans" asking for a minimum of 10 years of data exclusivity. The group boasts a membership that includes 50 of the nation's largest patient-advocacy groups, including the American Cancer Society, Easter Seals and the National Kidney Foundation. But its board of directors reads like a Who's Who of top pharmaceutical executives from Amgen, Pfizer, Novartis and Bristol Myers Squibb. Its 2007 tax filings show that almost half its $2.3 million budget came from PhRMA and drug companies...

Author: /time Magazine | Title: How Drug-Industry Lobbyists Won on Health-Care | 10/22/2009 | See Source »

...goal that has eluded them for more than two decades. "Having this signal - even if it's weak and even if we're debating whether it's a real signal or not - is a source of great hope," said Nicole Frahm, an HIV specialist at the Fred Hutchinson Cancer Research Center in Seattle, while attending the annual AIDS vaccine conference in Paris this week. "Up until now, we've had nothing. This holds the promise of a start...

Author: /time Magazine | Title: The AIDS Vaccine: Modest Results, but a Sign of Hope | 10/21/2009 | See Source »

Saccharin became mired in controversy in 1977, when a study indicated that the substance might contribute to cancer in rats. An FDA move to ban the chemical failed, though products containing saccharin were required to carry warning labels. In 2000, the chemical was officially removed from the Federal Government's list of suspected carcinogens. (Read TIME's 1974 article on cyclamate and saccharin...

Author: /time Magazine | Title: Are Artificial Sweeteners Really That Bad for You? | 10/20/2009 | See Source »

Previous | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | Next